Northeast Investment Management Merck & Co., Inc. Transaction History

Northeast Investment Management

$2.19 Billion
Q4 2024

A detailed history of Northeast Investment Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Northeast Investment Management holds 64,556 shares of MRK stock, worth $5.76 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

64,556

Previous 63,842 1.12%

Holding current value

$5.76 Million

Previous $7.25 Million 11.41%

% of portfolio

0.29%

Previous 0.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$96.31 - $114.76 $68,765 - $81,938	714 Added 1.12%	64,556 $6.42 Million
Q3 2024 Oct 29, 2024	BUY	$111.15 - $128.97 $269,316 - $312,494	2,423 Added 3.95%	63,842 $7.25 Million
Q2 2024 Jul 26, 2024	BUY	$123.8 - $132.96 $225,068 - $241,721	1,818 Added 3.05%	61,419 $7.6 Million
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $339,267 - $395,322	2,996 Added 5.29%	59,601 $7.86 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $462,030 - $502,800	-4,612 Reduced 7.53%	56,605 $6.17 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $84,521 - $93,864	821 Added 1.36%	61,217 $6.3 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $11,621 - $12,666	-107 Reduced 0.18%	60,396 $6.97 Million
Q1 2023 Apr 28, 2023	BUY	$102.94 - $114.86 $3,911 - $4,364	38 Added 0.06%	60,503 $6.44 Million
Q4 2022 Jan 27, 2023	SELL	$87.44 - $112.11 $155,992 - $200,004	-1,784 Reduced 2.87%	60,465 $6.71 Million
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $39,475 - $44,346	467 Added 0.76%	62,249 $5.36 Million
Q2 2022 Aug 05, 2022	SELL	$83.49 - $94.64 $42,997 - $48,739	-515 Reduced 0.83%	61,782 $5.63 Million
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $83,286 - $93,359	-1,133 Reduced 1.79%	62,297 $5.11 Million
Q4 2021 Feb 07, 2022	BUY	$72.28 - $90.54 $10,914 - $13,671	151 Added 0.24%	63,430 $4.86 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $351,805 - $386,897	-4,908 Reduced 7.2%	63,279 $4.75 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $1.82 Million - $2.02 Million	-25,911 Reduced 27.54%	68,187 $5.3 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $139,716 - $164,572	-2,029 Reduced 2.11%	94,098 $7.25 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $334,376 - $371,089	-4,659 Reduced 4.62%	96,127 $7.86 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $191,585 - $217,163	2,618 Added 2.67%	100,786 $8.36 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $492,094 - $559,948	6,988 Added 7.66%	98,168 $7.59 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $207,884 - $288,137	-3,281 Reduced 3.47%	91,180 $7.02 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $269,512 - $304,113	3,474 Added 3.82%	94,461 $8.59 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $305,004 - $332,466	4,009 Added 4.61%	90,987 $7.66 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $2.26 Million - $2.65 Million	32,419 Added 59.42%	86,978 $7.29 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $248,122 - $282,997	3,566 Added 6.99%	54,559 $4.54 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $711,246 - $825,390	10,902 Added 27.19%	50,993 $3.9 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $25,325 - $29,781	-439 Reduced 1.08%	40,091 $2.84 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $396,169 - $465,457	7,794 Added 23.81%	40,530 $2.46 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $70,120 - $81,500	-1,376 Reduced 4.03%	32,736 $1.78 Million
Q4 2017 Jan 29, 2018	SELL	$51.62 - $61.64 $41,812 - $49,928	-810 Reduced 2.32%	34,112 $1.92 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $2.05 Million - $2.2 Million	34,922	34,922 $2.24 Million

Others Institutions Holding MRK

# of Institutions

3,972

Shares Held

1.86B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $226B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Account

Northeast Investment Management Merck & Co., Inc. Transaction History